# Added Value of SVC Isolation in Patients With Pulmonary Vein Reconnection Undergoing Repeat Ablation for Recurrent Paroxysmal AF

> **NCT04602169** · NA · UNKNOWN · sponsor: **AZ Sint-Jan AV** · enrollment: 108 (estimated)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **PROCEDURE:** PVI
- **PROCEDURE:** PVI + SVC

## Key facts

- **NCT ID:** NCT04602169
- **Lead sponsor:** AZ Sint-Jan AV
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-16
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04602169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04602169, "Added Value of SVC Isolation in Patients With Pulmonary Vein Reconnection Undergoing Repeat Ablation for Recurrent Paroxysmal AF". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04602169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*